Value2021202220232024TTMSelling/general/admin expenses41.51 M55.82 M53.3 M46.95 M—Research & development26.58 M35.37 M36.97 M34.37 M—Operating income-67.61 M87.82 M74.83 M66.57 M—Non-Operating Income, Total—————Interest expense, net of interest capitalized—————Non-Operating Income, excl. Interest Expenses—————Unusual income/expense—————Pretax income73.51 M87.58 M78.5 M61.27 M—Equity in earnings—————Taxes168 K136 K486 K1.22 M—Non-controlling/minority interest—————After tax other income/expense—————Net income before discontinued operations73.67 M87.45 M78.98 M62.49 M—Discontinued operations—————Net income73.67 M87.45 M78.98 M62.49 M—Dilution adjustment—————Preferred dividends—————Diluted net income available to common stockholders—————Basic earnings per share (Basic EPS)—————Diluted earnings per share (Diluted EPS)—————Average basic shares outstanding—————Diluted shares outstanding—————EBITDA-123.65 M-145.17 M-144.73 M-141.2 M—EBIT-127.26 M-150.74 M-153.06 M-149.8 M—Cost of revenue15.23 M16.31 M19.46 M21.24 M—Other cost of goods sold—————Depreciation & amortization (cash flow)3.61 M5.57 M8.34 M8.6 M—
SOPHiA GENETICS SA
Sophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France. It provides genomic and radiomic, and multimodal analysis for hospitals, laboratories, and biopharma institutions.